Retinol and tretinoin: what the skin-ageing evidence shows

Why are the percentages not comparable?

Retinoic acid acts through receptors that regulate skin-cell behaviour; retinol is its precursor. Retinoid biology

Conversion is only part of the comparison. A product's base, stability and other ingredients also matter. A 1% retinol blend and 0.02% tretinoin are not a fifty-to-one measure of clinical strength. Nor does belonging to the same ingredient family make two finished products interchangeable.

The American Academy of Dermatology describes retinoids as increasing skin-cell turnover and influencing collagen. It advises considering the condition of the skin before starting: very dry, inflamed or redness-prone skin may need assessment rather than another active ingredient. Irritation can also cause dark marks, particularly in darker skin tones.

The distinction between a mechanism and a visible result matters here. A biopsy showing a change in collagen production helps explain how a treatment might work. The person using it still needs evidence that the appearance or symptom they care about improves enough to justify its drawbacks.

How long does use take, and what irritation should you expect?

The MedlinePlus information on topical tretinoin says wrinkle improvement may take three to four months, or as long as six months. Benefits may fade after treatment stops. It lists dryness, peeling, redness, itching, burning and stinging among possible side effects, and advises seeking medical advice when these are severe or persistent.

The six-month and year-long studies therefore fit a different expectation from a two-week product challenge. If a prescriber recommends treatment, agree when to review tolerability and when it is reasonable to assess visible benefit. Those need not be the same appointment: a troublesome reaction should be discussed before the planned cosmetic review.

For cosmetic retinol, the American Academy of Dermatology advises starting with a less intense formulation, introducing it gradually and using moisturiser. Its advice includes night-time application and sun protection. Follow the instructions for the actual product, and ask a pharmacist or clinician about combining it with other active skincare if irritation is a concern.

A simple example is someone who starts a retinol serum, an exfoliating acid and a new cleanser in the same week. If their skin becomes sore, it is harder to work out which change caused it. Bringing the full list of products to a consultation is more useful than discussing only the percentage of the newest serum.

The same applies to the product base. If a trial compares a particular cream with its vehicle, changing to a serum with a different mixture of ingredients changes more than the retinoid concentration. Keep the exact product name and formulation in the discussion.

Is the product suitable for you?

Tretinoin medicines in the UK require a prescription. The UK product information for Treclin, for example, identifies it as a prescription medicine combining tretinoin with the antibiotic clindamycin for acne. That is not a reason to choose an antibiotic combination for wrinkles. The intended condition, formulation and prescribing decision all matter.

For photoageing, discuss suitability with an appropriate prescriber rather than selecting a medicine from a cosmetic percentage comparison. The existence of a prescription product does not establish routine NHS provision for cosmetic treatment. Take your current skincare list, relevant medicines and history of skin reactions to that discussion.

The MHRA advises against topical retinoid medicines during pregnancy and when planning pregnancy. This is precautionary: systemic exposure from topical use is thought to be negligible, but risk cannot be excluded. Oral retinoids have separate pregnancy-prevention requirements. Ask a clinician or pharmacist about the exact product if pregnancy, planning pregnancy or breastfeeding is relevant; do not assume a cosmetic label settles the question.

Sun protection remains part of the plan. Topical tretinoin guidance warns about sunlight exposure and recommends protective clothing and sunscreen. Improving existing photodamage and reducing further ultraviolet exposure are complementary aims. Our guide to sunscreen and skin ageing explains the prevention evidence separately.

The most useful comparison is the exact concern you want to improve, the evidence for the proposed formulation, the months you are prepared to use it and the irritation you can tolerate. Those details give a prescriber or pharmacist something concrete to help you weigh. A larger percentage alone does not answer the decision.

What has cosmetic retinol been shown to improve?

A 2007 trial studied 36 older adults with an average age of 87. Investigators applied 0.4% retinol to one upper inner arm and the matching product base to the other for 24 weeks. This base, called the vehicle, lets researchers test whether the active ingredient adds anything beyond the cream itself.

Fine-wrinkle severity was rated on a scale from zero to nine. The average change was a reduction of 1.64 points with retinol, compared with 0.08 points with vehicle. That is a difference in a clinical rating scale, not a percentage of wrinkles erased. The treated area was sun-protected arm skin, so the size of that result cannot simply be transferred to a younger person's face.

Small biopsy subsets provided additional findings: six participants contributed to one tissue analysis and four to another. Those measurements are useful biological evidence, but they are much smaller samples than the headline trial size.

Facial studies do exist. A 2015 double-blind, vehicle-controlled study tested a stabilised 0.1% retinol product on the faces of 62 participants for a year and reported greater improvement in photodamage than vehicle. It also included a separate, small forearm tissue study. Several authors worked in the manufacturer's skin-research division.

That trial is more directly relevant to facial sun damage than the older arm study. It still supports the particular finished formula that was tested. An advert citing it for a different retinol serum should explain why its own product is comparable, rather than relying on the ingredient name alone.

What does the longer tretinoin evidence show?

A two-year trial published in 2005 treated 204 people with moderate to severe facial photodamage using 0.05% tretinoin or its vehicle. The tretinoin group improved more on clinical measures including fine and coarse wrinkling and mottled pigmentation. The abstract reports statistically significant differences but does not give a numerical improvement that can be translated honestly into a percentage for this guide.

A 1995 comparison followed people using 0.1% or 0.025% tretinoin for 48 weeks, with 99 completing the study. Clinical and tissue improvements were similar between those strengths, while redness and scaling were greater with the higher concentration.

That finding is useful when someone assumes the strongest product must produce the best result. It shows why tolerability is part of the treatment decision. It does not establish that the two strengths have identical effects in every condition or formulation.

These trials concern photodamage: changes associated with accumulated sun exposure. A product tested for fine wrinkles or mottled pigmentation has not thereby been shown to remove scars, tighten substantially loose skin or explain a new skin lesion. Being specific about the concern makes the evidence easier to use.

Did a direct comparison find them equally effective?

The 2022 trial compared 0.02% tretinoin with a blend of 1% retinol, 0.05% retinyl acetate and 0.05% retinyl palmitate. Twenty-four White women were randomised; twenty were analysed. SkinMedica funded it, reporting no role in conduct or reporting. At 24 weeks, median photodamage scores were four with the blend and five with tretinoin on a nine-point scale. The difference was minus one point, with a 95% confidence interval from minus two to plus one. That did not establish equivalence.

Redness occurred in 11% with the blend and 64% with tretinoin; other irritation measures did not differ significantly. This small comparison concerns those particular formulations. Trial results

Before choosing a product, define what would count as a worthwhile change for you. Is it the appearance of fine lines, uneven pigmentation, or something else? Pick the concern you will discuss at review. If you choose to take photographs, keep the lighting and angle consistent so that a different bathroom light does not become the apparent result. Also record tolerability: which days your skin felt comfortable, whether you changed the amount used, and whether other products changed. Bring that record to the review rather than trying to reconstruct several months from memory.

Hair thinning needs a separate comparison of treatments. Our rosemary oil and minoxidil guide examines the hair-growth evidence, including what the frequently cited head-to-head trial can actually establish.